FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163463258> ?p ?o ?g. }

• W2163463258 endingPage "629" @default.
• W2163463258 startingPage "618" @default.
• W2163463258 abstract "WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Ecological studies have shown conflicting evidence in relation to associations between trends in selective serotonin reuptake inhibitor (SSRI) prescription rates and suicide rates in adolescents. • After regulatory warnings in the UK against SSRI use in children and adolescents, prescribing of antidepressants in general declined in this group; there were no related changes in rates of suicide or hospital admissions for self‐harm. WHAT THIS STUDY ADDS • Based on all presentations to general hospitals, nonfatal self‐poisoning with SSRI antidepressants (but not fluoxetine) declined in 12–19‐year‐olds in three centres in England in line with UK prescribing trends. • There was some evidence of a possible small substitution effect from use of other SSRIs for nonfatal self‐poisoning to use of fluoxetine • Overall rates of nonfatal self‐harm in 12–19‐year‐olds in three centres in England were stable, indicating no major substitution of method to self‐injury or overall adverse impact of the Medicines and Healthcare products Regulatory Authority warning. AIMS To assess the impact of the UK Medicines and Healthcare products Regulatory Authority (MHRA) warning in December 2003 not to prescribe selective serotonin reuptake inhibitor (SSRI) antidepressants, except fluoxetine, to under‐18‐year‐olds. METHODS Interrupted time series analysis of prescriptions (UK) and general hospital presentations for nonfatal self‐poisoning (three centres in England) for 2000–2006. RESULTS Following the MHRA warning in December 2003 there were significant decreases in prescribing of SSRI antidepressants (conservative estimate 51%) to young people aged 12–19 years. Surprisingly, this decrease also affected fluoxetine (conservative estimate 20%) and tricyclics (conservative estimate 27%). Nonfatal self‐poisoning in this age group following the warning also declined significantly for SSRIs (conservative estimate 44%), but not for fluoxetine, tricyclic antidepressants, or all drugs and other substances. Rates of nonfatal self‐harm did not change significantly over the study period. CONCLUSIONS The reduction in both prescribing and self‐poisoning with SSRI antidepressants (except fluoxetine) following the MHRA warning is in keeping with reduced availability of these drugs. There was some evidence of substitution from other SSRIs to fluoxetine for use in self‐poisoning. Importantly, overall rates of nonfatal self‐harm and self‐poisoning did not change, indicating no substitution of method or increases in self‐injury." @default.
• W2163463258 created "2016-06-24" @default.
• W2163463258 creator A5000177470 @default.
• W2163463258 creator A5013137351 @default.
• W2163463258 creator A5016321309 @default.
• W2163463258 creator A5021170166 @default.
• W2163463258 creator A5058804524 @default.
• W2163463258 creator A5070985325 @default.
• W2163463258 creator A5086670121 @default.
• W2163463258 date "2009-10-01" @default.
• W2163463258 modified "2023-10-17" @default.
• W2163463258 title "Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds" @default.
• W2163463258 cites W1512725483 @default.
• W2163463258 cites W2011651292 @default.
• W2163463258 cites W2014076418 @default.
• W2163463258 cites W2017038172 @default.
• W2163463258 cites W2026943977 @default.
• W2163463258 cites W2028281254 @default.
• W2163463258 cites W2048012760 @default.
• W2163463258 cites W2080607579 @default.
• W2163463258 cites W2102926308 @default.
• W2163463258 cites W2106164880 @default.
• W2163463258 cites W2110132657 @default.
• W2163463258 cites W2119015267 @default.
• W2163463258 cites W2119566762 @default.
• W2163463258 cites W2120718750 @default.
• W2163463258 cites W2123869797 @default.
• W2163463258 cites W2131645291 @default.
• W2163463258 cites W2135488831 @default.
• W2163463258 cites W2137418606 @default.
• W2163463258 cites W2138479928 @default.
• W2163463258 cites W2150233559 @default.
• W2163463258 cites W2162271060 @default.
• W2163463258 cites W2164264709 @default.
• W2163463258 cites W2166303650 @default.
• W2163463258 doi "https://doi.org/10.1111/j.1365-2125.2009.03481.x" @default.
• W2163463258 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2780287" @default.
• W2163463258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19843065" @default.
• W2163463258 hasPublicationYear "2009" @default.
• W2163463258 type Work @default.
• W2163463258 sameAs 2163463258 @default.
• W2163463258 citedByCount "37" @default.
• W2163463258 countsByYear W21634632582012 @default.
• W2163463258 countsByYear W21634632582013 @default.
• W2163463258 countsByYear W21634632582014 @default.
• W2163463258 countsByYear W21634632582016 @default.
• W2163463258 countsByYear W21634632582017 @default.
• W2163463258 countsByYear W21634632582018 @default.
• W2163463258 countsByYear W21634632582019 @default.
• W2163463258 countsByYear W21634632582020 @default.
• W2163463258 countsByYear W21634632582021 @default.
• W2163463258 crossrefType "journal-article" @default.
• W2163463258 hasAuthorship W2163463258A5000177470 @default.
• W2163463258 hasAuthorship W2163463258A5013137351 @default.
• W2163463258 hasAuthorship W2163463258A5016321309 @default.
• W2163463258 hasAuthorship W2163463258A5021170166 @default.
• W2163463258 hasAuthorship W2163463258A5058804524 @default.
• W2163463258 hasAuthorship W2163463258A5070985325 @default.
• W2163463258 hasAuthorship W2163463258A5086670121 @default.
• W2163463258 hasBestOaLocation W21634632581 @default.
• W2163463258 hasConcept C118552586 @default.
• W2163463258 hasConcept C126322002 @default.
• W2163463258 hasConcept C142724271 @default.
• W2163463258 hasConcept C170493617 @default.
• W2163463258 hasConcept C187155963 @default.
• W2163463258 hasConcept C190385971 @default.
• W2163463258 hasConcept C194828623 @default.
• W2163463258 hasConcept C197934379 @default.
• W2163463258 hasConcept C2426938 @default.
• W2163463258 hasConcept C2775864247 @default.
• W2163463258 hasConcept C2776134451 @default.
• W2163463258 hasConcept C2779177272 @default.
• W2163463258 hasConcept C2780092697 @default.
• W2163463258 hasConcept C3017944768 @default.
• W2163463258 hasConcept C526869908 @default.
• W2163463258 hasConcept C558461103 @default.
• W2163463258 hasConcept C71924100 @default.
• W2163463258 hasConcept C98274493 @default.
• W2163463258 hasConceptScore W2163463258C118552586 @default.
• W2163463258 hasConceptScore W2163463258C126322002 @default.
• W2163463258 hasConceptScore W2163463258C142724271 @default.
• W2163463258 hasConceptScore W2163463258C170493617 @default.
• W2163463258 hasConceptScore W2163463258C187155963 @default.
• W2163463258 hasConceptScore W2163463258C190385971 @default.
• W2163463258 hasConceptScore W2163463258C194828623 @default.
• W2163463258 hasConceptScore W2163463258C197934379 @default.
• W2163463258 hasConceptScore W2163463258C2426938 @default.
• W2163463258 hasConceptScore W2163463258C2775864247 @default.
• W2163463258 hasConceptScore W2163463258C2776134451 @default.
• W2163463258 hasConceptScore W2163463258C2779177272 @default.
• W2163463258 hasConceptScore W2163463258C2780092697 @default.
• W2163463258 hasConceptScore W2163463258C3017944768 @default.
• W2163463258 hasConceptScore W2163463258C526869908 @default.
• W2163463258 hasConceptScore W2163463258C558461103 @default.
• W2163463258 hasConceptScore W2163463258C71924100 @default.
• W2163463258 hasConceptScore W2163463258C98274493 @default.
• W2163463258 hasIssue "4" @default.
• W2163463258 hasLocation W21634632581 @default.

• next